• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用质量检测同时量化高浓度生物制药中的表面活性剂含量和降解模式。

Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals.

作者信息

Kopf Robert, Paschen Christoph, Müller Lavinia, Kocar Berk, Wolfring Martin, Vincent Mathilde, Klemm Denis, Bell Christian, Pinto Cosimo

机构信息

F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland.

F. Hoffmann-La Roche AG, Grenzacherstrasse 24, CH-4070 Basel, Switzerland.

出版信息

J Pharm Biomed Anal. 2023 Nov 30;236:115651. doi: 10.1016/j.jpba.2023.115651. Epub 2023 Aug 15.

DOI:10.1016/j.jpba.2023.115651
PMID:37688908
Abstract

Non-ionic surfactants are commonly used in parenteral protein formulations and include polysorbate 20, polysorbate 80 and poloxamer188. Recently, quantification and characterization of surfactants has generated considerable interest due to their connection to visible particle formation, a critical quality attribute for parenteral formulations. Typically, surfactant quantification is performed by mixed mode chromatography with evaporative light scattering detection (ELSD) or charged aerosol detection (CAD). However, these methods often suffer from loss of specificity in highly concentrated protein formulations. Here we present a mixed mode chromatography method using single quad mass detection, overcoming current limitations for highly concentrated proteins. In addition to content determination of intact surfactants, this method allows to quantify and characterize the predominant degradation patterns of polysorbates within a single measurement. Formulations with up to 200 mg/mL active pharmaceutical product (API) containing surfactant levels between 0.16 and 0.64 mg/mL were tested during method qualification. The obtained results for linearity (r > 0.99), precision (max. 3.8 % RSD) and accuracy (96-116 % recovery) meet current requirements for pharmaceutical products as defined in ICH Q2.

摘要

非离子表面活性剂常用于肠胃外蛋白质制剂中,包括聚山梨酯20、聚山梨酯80和泊洛沙姆188。最近,由于表面活性剂与可见颗粒形成相关,而可见颗粒形成是肠胃外制剂的一个关键质量属性,因此对表面活性剂的定量和表征引起了相当大的关注。通常,表面活性剂的定量是通过带有蒸发光散射检测(ELSD)或带电气溶胶检测(CAD)的混合模式色谱法进行的。然而,这些方法在高浓度蛋白质制剂中常常存在特异性丧失的问题。在此,我们提出一种使用单四极杆质量检测的混合模式色谱法,克服了高浓度蛋白质的现有局限性。除了完整表面活性剂的含量测定外,该方法还允许在单次测量中对聚山梨酯的主要降解模式进行定量和表征。在方法验证期间,对含有0.16至0.64mg/mL表面活性剂水平、活性药物成分(API)浓度高达200mg/mL的制剂进行了测试。获得的线性(r>0.99)、精密度(最大相对标准偏差3.8%)和准确度(回收率96-116%)结果符合ICH Q2中规定的当前药品要求。

相似文献

1
Leveraging mass detection to simultaneously quantify surfactant content and degradation mode for highly concentrated biopharmaceuticals.利用质量检测同时量化高浓度生物制药中的表面活性剂含量和降解模式。
J Pharm Biomed Anal. 2023 Nov 30;236:115651. doi: 10.1016/j.jpba.2023.115651. Epub 2023 Aug 15.
2
Simultaneous quantification of polysorbate 20 and poloxamer 188 in biopharmaceutical formulations using evaporative light scattering detection.采用蒸发光散射检测法同时定量测定生物制药制剂中的聚山梨酯 20 和泊洛沙姆 188。
J Pharm Biomed Anal. 2021 Jan 5;192:113640. doi: 10.1016/j.jpba.2020.113640. Epub 2020 Sep 16.
3
Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay.单酯和多酯级分对采用混合模式高效液相色谱-蒸发光散射检测器/蒸发光散射检测器和荧光胶束分析法进行聚山梨酯定量分析的影响。
J Pharm Biomed Anal. 2017 Jan 5;132:24-34. doi: 10.1016/j.jpba.2016.09.033. Epub 2016 Sep 26.
4
Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.开发并验证了一种基于选择性标记的 UPLC QDa 检测法,用于生物制药制剂中聚山梨酯 20 的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Nov 10;1157:122287. doi: 10.1016/j.jchromb.2020.122287. Epub 2020 Jul 31.
5
Novel EDTA mediated ethanol protein precipitation method and the application for polysorbate quantification in high protein concentration biopharmaceuticals.新型 EDTA 介导的乙醇蛋白沉淀法及其在高浓度蛋白质生物制药中聚山梨酯定量分析中的应用。
J Pharm Biomed Anal. 2024 Aug 1;245:116145. doi: 10.1016/j.jpba.2024.116145. Epub 2024 Apr 10.
6
Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection.使用混合模式色谱法和蒸发光散射检测法对蛋白质溶液中的聚山梨酯20进行定量分析。
J Chromatogr A. 2008 Dec 26;1215(1-2):156-60. doi: 10.1016/j.chroma.2008.11.017. Epub 2008 Nov 14.
7
Determination of polysorbate 80 in parenteral formulations by high-performance liquid chromatography and evaporative light scattering detection.采用高效液相色谱法和蒸发光散射检测法测定注射用制剂中的聚山梨酯80。
J Chromatogr A. 2003 Sep 12;1012(1):81-6. doi: 10.1016/s0021-9673(03)01105-1.
8
High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations.高通量多维液相色谱法用于单克隆抗体制剂中聚山梨酯和泊洛沙姆在线蛋白去除和特性分析。
J Chromatogr A. 2024 Apr 12;1720:464777. doi: 10.1016/j.chroma.2024.464777. Epub 2024 Feb 27.
9
Development of a simple high performance liquid chromatography (HPLC)/evaporative light scattering detector (ELSD) method to determine Polysorbate 80 in a pharmaceutical formulation.开发一种简单的高效液相色谱(HPLC)/蒸发光散射检测器(ELSD)方法,用于测定药物制剂中的聚山梨酯80。
Saudi Pharm J. 2020 Mar;28(3):325-328. doi: 10.1016/j.jsps.2020.01.012. Epub 2020 Jan 31.
10
Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.多维超高效液相色谱-电喷雾检测-质谱法分析治疗性单克隆抗体制剂中聚山梨酯 20 的特性和稳定性。
Anal Chem. 2014 May 20;86(10):5150-7. doi: 10.1021/ac5009628. Epub 2014 May 2.